|
Market Closed -
Other stock markets
|
After market 11:45:49 | |||
| 2.56 EUR | -1.54% |
|
2.575 | +0.59% |
| 07-11 | Heidelberg Pharma AG Reports Earnings Results for the Half Year Ended May 31, 2024 | CI |
| 04-25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Heidelberg Pharma AG reported earnings results for the half year ended May 31, 2024. For the half year, the company reported sales was EUR 4.05 million compared to EUR 4.39 million a year ago. Revenue was EUR 6.28 million compared to EUR 4.67 million a year ago.
Net loss was EUR 8.67 million compared to EUR 15.95 million a year ago. Basic loss per share from continuing operations was EUR 0.19 compared to EUR 0.34 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.55% | 132M | |
| +21.25% | 127B | |
| +24.39% | 117B | |
| +25.44% | 27.67B | |
| -18.94% | 20.33B | |
| -15.17% | 16.79B | |
| -16.33% | 15.63B | |
| +12.70% | 14.84B | |
| -47.10% | 14.65B | |
| +57.11% | 14.43B |
HEIDELBERG PHARMA AG 
